Retinoids are a class of polyisoprenoid lipids structurally related to vitamin A, that can have dramatic affects on the growth and differentiation of both normal and transformed cells. The differentiation of epithelial cells in general, and epidermal cells in particular, is extremely sensitive to retinoic acid. Direct antiproliferative affects of retinoic acid, often associated with a commitment to differentiation, have been demonstrated in myeloid leukemia, breast cancer, embryonal carcinoma, neuroblastoma, and melanoma cells. These generalized effects on cellular phenotype suggest that the likely mechanism of retinoid action is through selective alterations in gene expression of responsive cells, in a manner analogous to steroid hormones. However, progress into the mechanism of action of retinoids has been hampered by a lack of identifiable indices of eh direct effects of retinoids on gene expression. We have shown that retinoic acid directly enhances the transcription rate of the tissue transglutaminase gene in macrophages and HL-60 cells; thus the regulation of tissue transglutaminase gene expression will serve as a useful endpoint with which to investigate the molecular mechanism of retinoid action. We have cloned the mouse tissue transglutaminase gene, and propose to characterized the retinoid response element that mediates retinoic acid regulation. We will identify, through deletion mapping and transfection experiments, regions of he gene required for retinoid induced expression. Gel retardation and footprinting studies with purified receptor preparations will permit the identification of specific domains that contain retinoid regulatory elements. The precise boundaries of the response element(s) will then be determined using mutagenesis studies. These experiments will allow us to explore in detail the specific regulatory effect of retinoic acid on gene expression. The information we derive form these experiments should provide the initial progress toward an understanding of how retinoids affect cellular growth and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041829-09
Application #
2090522
Study Section
Endocrinology Study Section (END)
Project Start
1989-12-01
Project End
1995-04-30
Budget Start
1993-05-01
Budget End
1995-04-30
Support Year
9
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Upstate Medical University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Yan, Z H; Noonan, S; Nagy, L et al. (1996) Retinoic acid induction of the tissue transglutaminase promoter is mediated by a novel response element. Mol Cell Endocrinol 120:203-12
Kent, T A; Messina, J L; Weinstock, R S et al. (1994) Synergistic induction of gene 33 expression by retinoic acid and insulin. Endocrinology 134:2237-44
Gentile, V; Saydak, M; Chiocca, E A et al. (1991) Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 266:478-83
Chiocca, E A; Davies, P J; Stein, J P (1989) Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation. J Cell Biochem 39:293-304
Chiocca, E A; Davies, P J; Stein, J P (1988) The molecular basis of retinoic acid action. Transcriptional regulation of tissue transglutaminase gene expression in macrophages. J Biol Chem 263:11584-9
Davies, P J; Chiocca, E A; Basilion, J P et al. (1988) Transglutaminases and their regulation: implications for polyamine metabolism. Adv Exp Med Biol 250:391-401
Davies, P J; Basilion, J P; Chiocca, E A et al. (1988) Retinoids as generalized regulators of cellular growth and differentiation. Am J Med Sci 296:164-70